Dalle nostre riviste

Farmeconomia. Health Economics and Therapeutic Pathways

A general model for the estimation of societal costs of lost production and informal care in Italy

Lorenzo Pradelli, Gianni Ghetti

The cost of a combination Anti-Retroviral Therapy (cART) optimization pathway as maintenance therapy in HIV-1 infected patients

Roberto Ravasio, Fabio Rigo, Emanuela Lattuada, Ercole Concia, Massimiliano Lanzafame

Evaluation of the cost saving potential of introducing Benepali® and Flixabi® on the European and Italian markets

Cristina Negrini, Emi Psachoulia

Economic implications in inflammatory bowel disease: results from a retrospective analysis in an Italian Centre

Angela Variola, Arianna Massella, Andrea Geccherle, Paolo Bocus, Roberto Tessari, Teresa Zuppini, Roberto Ravasio

Cost-effectiveness analysis of empagliflozin in the treatment of patients with type 2 diabetes and established cardiovascular disease in Italy, based on the results of the EMPA-REG OUTCOME study

Sergio Iannazzo, Edoardo Mannucci, Odette Reifsnider, Aldo Pietro Maggioni

Budget impact analysis of dabigatran compared with rivaroxaban in the prevention of the thromboembolic risk in patients with non-valvular atrial fibrillation

Maria Grazia Celeste, Francesca De Marco, Claudio Fresco, Giuseppe Musumeci, Roberto Ravasio

Varenicline treatment for smoking cessation in high risk patients: a budget impact analysis

Federico Spandonaro, Letizia Mancusi, Barbara Polistena

Budget Impact analysis of the first-line treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) adult patients

Francesco Mennini, Andrea Marcellusi, Raffaella Viti, Giuseppe Saglio

Equilibrium between resources and expenditure of health sector of Social Security Fund: a case study of Iran

Azadeh Ahmadi Dashtian, Mohsen Mardali

Recently approved recombinant factor VIII (rFVIII) for the replacement treatment in patients with hemophilia A in Italy

Daniela Paola Roggeri, Ezio Zanon, Alessandro Roggeri

[Use of Kovaltry® in patients with Hemophilia A: clinical and economical aspects from the pivotal clinical trials]

Lucia Sara D'Angiolella, Angelo Claudio Molinari, Paolo Angelo Cortesi, Antonio Coppola, Lorenzo Giovanni Mantovani

[In reference to "Clinical and economic evaluation of the introduction of the combinazion trametinib + dabrafenib in the management of advanced melanoma in the Italian market”]

Matteo Ferrario, Giovanni Giuliani

[Reply to Letter to the Editor in reference to " Clinical and economic evaluation of the introduction of the combinazion trametinib + dabrafenib in the management of advanced melanoma in the Italian market”]

Lorenzo Pradelli, Paolo Ascierto

Utilization patterns of complementary and alternative medicine in Australia, Canada and the United States: popularity of dietary supplements, mind-body and manipulative therapies

Marina Luketina Sunjka, Ana Pejcic, Mihajlo Jakovljevic